These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Multiple myeloma and acute leukemia associated with alkylating agents. Kyle RA; Pierre RV; Bayrd ED Arch Intern Med; 1975 Jan; 135(1):185-92. PubMed ID: 1053891 [TBL] [Abstract][Full Text] [Related]
3. [Therapy results and clinical course in 91 cases of multiple myeloma with regard to their clinical staging (author's transl)]. Rubio Felix D; Giraldo MP; Raichs A; García Zueco JC; Mur P; Faura MV; Ruíz-Marcuello E; Piñan MA Sangre (Barc); 1980; 25(1):25-34. PubMed ID: 7384962 [No Abstract] [Full Text] [Related]
4. Breast cancer and acute leukemia in a patient with multiple myeloma treated with melphalan. Meytes D; Katz DR Isr J Med Sci; 1973 Aug; 9(8):1044-7. PubMed ID: 4753846 [No Abstract] [Full Text] [Related]
6. [Results of combined treatment of advanced forms of multiple myeloma with vincristine, melphalan, cyclophosphamide and prednisone (VMCP) and with vincristine, doxorubicin, cyclophosphamide and prednisone (VDCP)]. Robak T; Krykowski E; Płuzańska A; Olszańska-Skorek T; Urbańska-Ryś H; Polkowska-Kulesza E; Błasińska-Morawiec M; Mazurowa A Pol Tyg Lek; 1983 Apr; 38(16):481-4. PubMed ID: 6579509 [No Abstract] [Full Text] [Related]
7. [Dysmyelopoietic syndrome 7 years after melphalan treatment of multiple myeloma. Clinical case]. Scolozzi R; Boccafogli A Minerva Med; 1983 Jul; 74(28-29):1783-5. PubMed ID: 6866310 [TBL] [Abstract][Full Text] [Related]
8. Prognostic factors and survival in multiple myeloma. Analysis of 91 cases treated by melphalan and prednisone. Gobbi M; Cavo M; Savelli G; Baccarani M; Tura S Haematologica; 1980 Aug; 65(4):437-45. PubMed ID: 6774915 [No Abstract] [Full Text] [Related]
9. [Acute myelogenous leukemia in myelomatosis]. Tidsskr Nor Laegeforen; 1977 Feb; 97(4):175-7. PubMed ID: 265102 [No Abstract] [Full Text] [Related]
10. Erythroleukemia following melphalan therapy for multiple myeloma. Fishman SA; Ritz ND N Y State J Med; 1975 Nov; 75(13):2402-4. PubMed ID: 1059018 [No Abstract] [Full Text] [Related]
11. [Myeloma, melphalan and acute myelo-monocytic leukemia. Apropos of a case]. Cywiner-Golenzer C; Adotti F; Marsan C; Quillard A; Henon P; Grimaldi A; Dryll A Sem Hop; 1974 Jan; 50(3):207-11. PubMed ID: 4367926 [No Abstract] [Full Text] [Related]
12. Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: updated time-to-events results and prognostic factors for time to progression. Mateos MV; Hernández JM; Hernández MT; Gutiérrez NC; Palomera L; Fuertes M; Garcia-Sanchez P; Lahuerta JJ; de la Rubia J; Terol MJ; Sureda A; Bargay J; Ribas P; Alegre A; de Arriba F; Oriol A; Carrera D; García-Laraña J; García-Sanz R; Bladé J; Prósper F; Mateo G; Esseltine DL; van de Velde H; San Miguel JF Haematologica; 2008 Apr; 93(4):560-5. PubMed ID: 18322252 [TBL] [Abstract][Full Text] [Related]
13. Melphalan-prednisone versus alternating combination VAD/MP or VND/MP as primary therapy for multiple myeloma: final analysis of a randomized clinical study. Cavo M; Benni M; Ronconi S; Fiacchini M; Gozzetti A; Zamagni E; Cellini C; Tosi P; Baccarani M; Tura S; Haematologica; 2002 Sep; 87(9):934-42. PubMed ID: 12217805 [TBL] [Abstract][Full Text] [Related]
14. [Sideroblastic anemia in a multiple myeloma treated by melphalan (author's transl)]. Phelip X; Grosclaude S; Rouge P; Mouries D; Blanc D Sem Hop; 1979 Oct 18-25; 55(35-36):1633-5. PubMed ID: 231836 [TBL] [Abstract][Full Text] [Related]
15. Comparison of melphalan and prednisone with vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of multiple myeloma: results of Eastern Cooperative Oncology Group Study E2479. Oken MM; Harrington DP; Abramson N; Kyle RA; Knospe W; Glick JH Cancer; 1997 Apr; 79(8):1561-7. PubMed ID: 9118039 [TBL] [Abstract][Full Text] [Related]
16. Alkeran and multiple myeloma. Med Lett Drugs Ther; 1966 Apr; 8(8):32. PubMed ID: 5913764 [No Abstract] [Full Text] [Related]
17. [Acute leukemia and myeloma]. Riedler GF; Vorburger E; Maier C Schweiz Med Wochenschr; 1972 Nov; 102(44):1592-4. PubMed ID: 4509370 [No Abstract] [Full Text] [Related]
18. [Case of IgG-K myeloma successfully treated with melphalan but terminating in acute myelogenous leukemia 2 years and 8 months later]. Saitoh A; Tsushima T; Narita K; Fujiwara S; Kawamura S; Chiba Y; Yoshida Y Rinsho Ketsueki; 1982 Jun; 23(6):862-9. PubMed ID: 6960198 [No Abstract] [Full Text] [Related]
19. A case of multiple myeloma terminating with acute myelomonocytic leukemia after long-term melphalan therapy. Ota H; Ikeda Y; Shibata T; Hirabayashi N Nihon Ketsueki Gakkai Zasshi; 1974 Feb; 37(1):49-57. PubMed ID: 4526861 [No Abstract] [Full Text] [Related]
20. Multiple myeloma terminating in acute leukemia: report of two cases and review of the literature. Martínez-Poventud G; Fernández AC; Vélez-García E Bol Asoc Med P R; 1985 Oct; 77(10):419-21. PubMed ID: 3865657 [No Abstract] [Full Text] [Related] [Next] [New Search]